{"transactions":[{"id":3619218,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2019-03-05T02:09:19.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":16269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vested in three equal annual installments beginning on the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vested in three equal annual installments beginning on the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16269},"source":{"system":"sec-edgar","filing":"0001019056-19-000184","document":"stromatt.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000184/stromatt.xml","form_type":"4"}},{"id":3619217,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-05T02:09:19.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three approximately equal annual installments beginning on February 28, 2020."}],"balance_after":67400,"derivative":{"exercise_price":1.52,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-19-000184","document":"stromatt.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000184/stromatt.xml","form_type":"4"}},{"id":3619216,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2019-03-05T02:09:19.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":4823,"price":1.57,"value":7572.11,"ownership":{"direct":true},"balance_after":216183,"source":{"system":"sec-edgar","filing":"0001019056-19-000184","document":"stromatt.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000184/stromatt.xml","form_type":"4"}},{"id":3619215,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2019-03-05T02:09:19.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":16269,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."}],"balance_after":221006,"source":{"system":"sec-edgar","filing":"0001019056-19-000184","document":"stromatt.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000184/stromatt.xml","form_type":"4"}},{"id":3998474,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2018-03-14T01:40:18.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":13892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018."}],"balance_after":16269,"derivative":{"underlying":"Common Stock","underlying_shares":13892},"source":{"system":"sec-edgar","filing":"0001019056-18-000439","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000439/stromatt_4.xml","form_type":"4"}},{"id":3998473,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2018-03-14T01:40:18.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":67400,"derivative":{"exercise_price":3.13,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-18-000439","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000439/stromatt_4.xml","form_type":"4"}},{"id":3998472,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2018-03-14T01:40:18.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":13892,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":204737,"source":{"system":"sec-edgar","filing":"0001019056-18-000439","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000439/stromatt_4.xml","form_type":"4"}},{"id":4015586,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2018-03-06T00:36:59.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":16269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date."}],"balance_after":30161,"derivative":{"underlying":"Common Stock","underlying_shares":16269},"source":{"system":"sec-edgar","filing":"0001019056-18-000416","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000416/stromatt_4.xml","form_type":"4"}},{"id":4015585,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2018-03-06T00:36:59.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":16269,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":190845,"source":{"system":"sec-edgar","filing":"0001019056-18-000416","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000416/stromatt_4.xml","form_type":"4"}},{"id":4073824,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2018-02-07T00:23:32.000Z","date":"2018-02-03","kind":"exercise","acquired":false,"shares":27381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."}],"balance_after":46430,"derivative":{"underlying":"Common Stock","underlying_shares":27381},"source":{"system":"sec-edgar","filing":"0001019056-18-000291","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000291/stromatt_4.xml","form_type":"4"}},{"id":4073823,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2018-02-07T00:23:32.000Z","date":"2018-02-03","kind":"exercise","acquired":true,"shares":27381,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":174576,"source":{"system":"sec-edgar","filing":"0001019056-18-000291","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000291/stromatt_4.xml","form_type":"4"}},{"id":4243743,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2017-08-03T20:00:49.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":78123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were issued on August 3, 2016 and fully vested on August 1, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were issued on August 3, 2016 and fully vested on August 1, 2017."}],"balance_after":73811,"derivative":{"underlying":"Common Stock","underlying_shares":78123},"source":{"system":"sec-edgar","filing":"0001019056-17-000649","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000649/stromatt_4.xml","form_type":"4"}},{"id":4243742,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2017-08-03T20:00:49.000Z","date":"2017-08-01","kind":"exercise","acquired":true,"shares":78123,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":147195,"source":{"system":"sec-edgar","filing":"0001019056-17-000649","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000649/stromatt_4.xml","form_type":"4"}},{"id":4298217,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-02T01:41:46.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the \"Plan\") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on June 1, 2018."}],"balance_after":33700,"derivative":{"exercise_price":2.15,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001019056-17-000550","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000550/stromatt_4.xml","form_type":"4"}},{"id":4388807,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-10","kind":"exercise","acquired":false,"shares":24836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017."}],"balance_after":151934,"derivative":{"underlying":"Common Stock","underlying_shares":24836},"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4388806,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-09","kind":"exercise","acquired":false,"shares":13902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 13,902 on March 9, 2017 and 13,892 on March 9, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 13,902 on March 9, 2017 and 13,892 on March 9, 2018."}],"balance_after":176770,"derivative":{"underlying":"Common Stock","underlying_shares":13902},"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4388805,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":16269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date."}],"balance_after":190672,"derivative":{"underlying":"Common Stock","underlying_shares":16269},"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4388804,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":6570,"price":1.78,"value":11694.6,"ownership":{"direct":true},"balance_after":69072,"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4388803,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-10","kind":"exercise","acquired":true,"shares":24836,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":75642,"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4388802,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-09","kind":"tax_withholding","acquired":false,"shares":3678,"price":1.8,"value":6620.4,"ownership":{"direct":true},"balance_after":50806,"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4388801,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-09","kind":"exercise","acquired":true,"shares":13902,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":54484,"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4388800,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":5312,"price":2.02,"value":10730.24,"ownership":{"direct":true},"balance_after":40582,"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4388799,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:03.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":16269,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":45894,"source":{"system":"sec-edgar","filing":"0001019056-17-000286","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000286/stromatt_4.xml","form_type":"4"}},{"id":4421752,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-27T21:05:27.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal annual installments beginning on February 24, 2018."}],"balance_after":236580,"derivative":{"exercise_price":1.96,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001019056-17-000238","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000238/stromatt_4.xml","form_type":"4"}},{"id":4461613,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2017-02-08T23:31:08.000Z","date":"2017-02-03","kind":"exercise","acquired":false,"shares":27381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."}],"balance_after":206941,"derivative":{"underlying":"Common Stock","underlying_shares":27381},"source":{"system":"sec-edgar","filing":"0001019056-17-000113","document":"stromatt_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000113/stromatt_4.xml","form_type":"4"}},{"id":4461612,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Common Stock","published_at":"2017-02-08T23:31:08.000Z","date":"2017-02-03","kind":"exercise","acquired":true,"shares":27381,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":29625,"source":{"system":"sec-edgar","filing":"0001019056-17-000113","document":"stromatt_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000113/stromatt_4.xml","form_type":"4"}},{"id":4594223,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2016-09-27T19:43:36.000Z","date":"2016-08-03","kind":"grant","acquired":true,"shares":78123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the right of the reporting person to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This report has been amended to reflect that the RSUs will vest on August 1, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This report has been amended to reflect that the RSUs will vest on August 1, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This report has been amended to reflect the 101,437 RSUs that were originally issued by Emergent and, as a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, were adjusted and assumed by the Issuer under its Converted Equity Awards Incentive Plan."}],"balance_after":234322,"derivative":{"underlying":"Common Stock","underlying_shares":78123},"source":{"system":"sec-edgar","filing":"0001019056-16-001559","document":"stromatt_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905616001559/stromatt_4a.xml","form_type":"4/A","original_submission_date":"2016-08-05"}},{"id":4594222,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":159607,"kind":"person","name":"Stromatt Scott C","position":1,"cik":"0001679975","reported_name":"Stromatt Scott C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and SVP"}}],"security":"Restricted Stock Unit","published_at":"2016-09-27T19:43:36.000Z","date":"2016-08-03","kind":"grant","acquired":true,"shares":54762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the right of the reporting person to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This report has been amended to reflect that the RSUs will vest in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This report has been amended to reflect that the RSUs will vest in two equal installments on February 3, 2017 and February 3, 2018."}],"balance_after":54762,"derivative":{"underlying":"Common Stock","underlying_shares":54762},"source":{"system":"sec-edgar","filing":"0001019056-16-001559","document":"stromatt_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905616001559/stromatt_4a.xml","form_type":"4/A","original_submission_date":"2016-08-05"}}]}